There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
The company has accelerated the development of CLIA-waived Xpert test (targeted toward flu) and expects the product to be available in the US during the 2013–14 flu season. However, the current economic uncertainty continues to be a major headwind for...
Inc. , a biotechnology and pharmaceutical development company that was spun off from Utah’s Myriad Genetics in 2009, has reported its second-quarter financial results. The company, which is headquartered in Salt Lake City, reported a loss of $7.5...
Genetics (NASDAQ: MYGN)‘s stock had its “neutral” rating reiterated by Zacks Investment Research in a research note issued on Friday. They currently have a $25.00 price target on the stock. Zacks‘ analyst wrote, “Myriad reported a strong second quarter...
Chaplin loads patient samples into a machine for testing at Myriad Genetics in Salt Lake City. A new report shows the rapidly expanding genetic and genomic clinical laboratory testing industry in the United States currently supports 116,000 jobs and...
RAD51C will be used to test patients' hereditary breast and ovarian cancer risks. “I think it is unfortunate for both the clinical and research communities”, Jim Evans (University ... To read this article in full you will need to login or make a...
Genetics, Inc. (Nasdaq: MYGN) announced that a presentation entitled, "Validation of a panel of cell-cycle progression genes for improved risk-stratification in a contemporary radical prostatectomy cohort," was presented on Thursday, February, 2, 2012...
Genetics (NASDAQ: MYGN)‘s stock had its “buy” rating reiterated by analysts at Auriga in a research report issued to clients and investors on Wednesday. Separately, analysts at Goldman Sachs (NYSE: GS) reiterated a “neutral” rating on shares of Myriad...
There are no results for this module. Edit this module to change the search term used to query Wikipedia
There are no results for this module. Edit the module to change the search term used to query related quotes.
We found no quotes related to Myriad Genetics, Inc..
